Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation & Amortization (IS)EBIATMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares IssuedShares RepurchasedShort-Term Debt repayments
Ratios

Ani Pharmaceuticals (ANIP) Short-Term Debt issuances (2017 - 2021)

Historic Short-Term Debt issuances for Ani Pharmaceuticals (ANIP) over the last 5 years, with Q4 2021 value amounting to $262.0 million.

  • Ani Pharmaceuticals' Short-Term Debt issuances rose 184688.0% to $262.0 million in Q4 2021 from the same period last year, while for Dec 2021 it was $286.0 million, marking a year-over-year change of. This contributed to the annual value of $286.0 million for FY2021, which is N/A changed from last year.
  • Ani Pharmaceuticals' Short-Term Debt issuances amounted to $262.0 million in Q4 2021, which was up 184688.0% from $24.0 million recorded in Q2 2021.
  • Ani Pharmaceuticals' 5-year Short-Term Debt issuances high stood at $262.0 million for Q4 2021, and its period low was -$15.0 million during Q4 2020.
  • In the last 3 years, Ani Pharmaceuticals' Short-Term Debt issuances had a median value of $19.5 million in 2020 and averaged $51.8 million.
  • Examining YoY changes over the last 5 years, Ani Pharmaceuticals' Short-Term Debt issuances showed a top increase of 184688.0% in 2021 and a maximum decrease of 184688.0% in 2021.
  • Over the past 3 years, Ani Pharmaceuticals' Short-Term Debt issuances (Quarter) stood at -$5.0 million in 2017, then crashed by 200.0% to -$15.0 million in 2020, then soared by 1846.88% to $262.0 million in 2021.
  • Its Short-Term Debt issuances stands at $262.0 million for Q4 2021, versus $24.0 million for Q2 2021 and -$15.0 million for Q4 2020.